A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

Clinical trial NCT07579936 · RECRUITING

Trial details

NCT number: NCT07579936
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Postmenopausal Women With Osteoporosis

Start date: 2026-04-30
Primary completion: 2026-07-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.